Restoring TB-specific immunity in early HIV infection—the dual promise of early antiretroviral and TB preventive treatment

Abstract

Early HIV infection disrupts TB-specific immunity, raising TB risk before CD4 decline. Early ART may help but cannot fully restore function, making tuberculosis preventive treatment indispensable—potentially lifelong—to close immunologic gaps and reduce HIV-associated TB morbidity and mortality.